Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. Our performance against environmental, social and governance (ESG) criteria is reflected in various third-party ratings.

Industry-leading performance across priority ESG ratings

RatingScore1Position / Status
Access to Medicine Index (ATMI)3.874th (in the leadership group for 10 years)
CDP Climate ChangeADouble A List
CDP Water SecurityA
ISS ESGBLeader status
MSCIAALeader status
Sustainalytics*16.2Low Risk category

For more information on our awards and recognition, please click here.

Last update: October 2023

1. Scales: ATMI: 1 to 5; CDP: D- to A; ISS ESG: D- to A+ ; MSCI: CCC to AAA; Sustainalytics ESG Risk Rating: 0 (Negligible risk) to 40+ (Severe risk)

* Copyright © 2023 Morningstar Sustainalytics. All rights reserved. This publication contains information developed by Sustainalytics ( Such information and data are proprietary of Sustainalytics and/or its third-party suppliers (Third Party Data) and are provided for informational purposes only. They do not constitute an endorsement of any product or project, nor an investment advice and are not warranted to be complete, timely, accurate or suitable for a particular purpose. Their use is subject to conditions available at